Trial intelligence / Profile preview

Effect of pramipexole versus no treatment in migraine patients with restless legs syndrome

IRCT201506019014N63Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of pramipexole in migraine and restless legs syndrome (RLS) (2 arms), sponsored by Hamadan University of Medical Sciences. Started Sep 2014; status: completed.

02

Drugs

pramipexole
03

Conditions

migrainerestless legs syndrome (RLS)

Beyond the preview

Go deeper on IRCT201506019014N63.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201506019014N63.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call